Skip to main content
SpringerLink
Log in

Reduction of Polypharmacy in the Elderly

A Systematic Review of the Role of the Pharmacist

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Polypharmacy in the elderly complicates therapy, increases cost, and is a challenge for healthcare agencies. In the context of the evolving role of the pharmacist, this systematic review examines the effectiveness of interventions led by pharmacists in reducing polypharmacy.

A computerised search was conducted using Medline, Embase geriatrics and gerontology (2001 edition), the Cochrane Library and International Pharmaceutical Abstracts (IPA) databases. A manual search of articles on polypharmacy and the role of pharmacists in the therapy of the elderly and of the reference sections of all retrieved articles was also carried out. Search terms used were ‘polypharmacy’, ‘elderly’, ‘aged’, ‘intervention’ and ‘pharmacist(s)’. Articles that fulfilled the following criteria were included: only elderly people were included in the study, or all ages were included but the study gave separate results for the elderly; the outcome was expressed as a reduction in the number of medications; a pharmacist participated in the study; and the study was a controlled or a randomised controlled study.

We initially identified 106 articles, but only 14 studies met our four inclusion criteria. Reduction in the number of medications was not the major purpose of most selected studies but often a secondary outcome. Objectives differed, the general aim being to enhance the quality of prescribing in elderly patients. These controlled studies argued in favour of the effectiveness of pharmacists’ interventions, even though the number of medications eliminated was small. Most studies were not designed to demonstrate the impact of reducing the number of drugs on the clinical consequences of polypharmacy (nonadherence, adverse drug reactions, drug-drug interactions, increased risk of hospitalisation, and medication errors).

The most frequently reported outcome related to cost savings. It was therefore difficult to assess whether the interventions benefited the patient. The methodological quality of many identified studies was poor. In particular, the study objectives were often very broad and ill-defined. Polypharmacy itself has been defined in different ways and the appropriate definition may differ according to the patient population and the study setting.

Further studies are needed to find the most effective way to reduce polypharmacy, especially in the frail elderly population, and to quantify the real advantages of simplifying their drug regimens in terms of improved quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III
Table IV

Similar content being viewed by others

References

  1. McLeod DC. Contribution of clinical pharmacists to patient care. Am J Hosp Pharm1976; 33: 904–11

    PubMed  CAS  Google Scholar 

  2. Denham MJ, Barnett NL. Drug therapy and the older person: role of the pharmacist. Drug Saf 1998; 19(4): 243–50

    Article  PubMed  CAS  Google Scholar 

  3. American College of Physicians, American Society of Internal Medicine. Pharmacist scope of practice. Ann Intern Med 2002; 136: 79–85

    Google Scholar 

  4. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533–43

    PubMed  CAS  Google Scholar 

  5. Omori DM, Potyk RP, Kroenke K. The adverse effects of hospitalisation on drug regimens. Arch Intern Med 1991; 151: 1562–4

    Article  PubMed  CAS  Google Scholar 

  6. Kroenke K, Pinholt EM. Reducing polypharmacy in the elderly: a controlled trial of physician feedback. J Am Geriatr Soc 1990; 38: 31–6

    PubMed  CAS  Google Scholar 

  7. Meyer TJ, Van Kooten D, Marsh S, et al. Reduction of polypharmacy by feedback to clinicians. J Gen Intern Med 1991; 6: 133–6

    Article  PubMed  CAS  Google Scholar 

  8. Montamat SC, Cusack B. Overcoming problems with polypharmacy and drug misuse in the elderly. Clin Geriatr Med 1992; 8(1): 143–58

    PubMed  CAS  Google Scholar 

  9. Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49(2): 200–9

    Article  PubMed  CAS  Google Scholar 

  10. Beers MH, Munekata M, Storrie M. The accuracy of medication histories in the hospital medical records of elderly persons. J Am Geriatr Soc 1990; 38: 1183–7

    PubMed  CAS  Google Scholar 

  11. Barat I, Andreasen F, Damsgaard EMS. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000; 56: 501–9

    Article  PubMed  CAS  Google Scholar 

  12. Lamy PP. New dimensions and opportunities. Drug Intell Clin Pharm 1985; 19: 399–402

    PubMed  CAS  Google Scholar 

  13. Kennerfalk A, Ruigomez A, Wallander MA, et al. Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother 2002; 36: 797–803

    Article  PubMed  Google Scholar 

  14. Thomas HF, Sweetnam PM, Janchawee B, et al. Polypharmacy among older males in South Wales. Eur J Clin Pharmacol 1999; 55: 411–5

    Article  PubMed  CAS  Google Scholar 

  15. Bjerrum L, Sogaard J, Hallas J,et al. Polypharmacy: correlation with sex, age and drug regimen. Eur J Clin Pharmacol 1998; 54: 197–202

    Article  PubMed  CAS  Google Scholar 

  16. Jeandel C, Graille M, Ferry JC. La prescription médicamenteuse chez la personne âgée: a propos d’une enquête dans la région Nord-Est. Rev Geriatr 1996; 21(7): 483–7

    Google Scholar 

  17. Fourrier A, Letenneur L, Dartigues J, et al. Consommation médicamenteuse chez le sujet âgé vivant à domicile et en institution à partir de la cohorte Paquid: importance de la polymédication et utilisation des psychotropes. Rev Geriatr 1996; 21(7): 473–82

    Google Scholar 

  18. Espino DV, Lichtenstein MJ, Hazuda HP, et al. Correlates of prescription and over-the-counter medication usage among older Mexican Americans: The Hispanic EPESE study. J Am Geriatr Soc 1998; 46: 1228–34

    PubMed  CAS  Google Scholar 

  19. Blenkiron P. The elderly and their medication: understanding and compliance in a family practice. Postgrad Med J 1996; 72: 671–6

    Article  PubMed  CAS  Google Scholar 

  20. Stoehr GP, Ganguli M, Seaberg EC, et al. Over-the-counter medication use in an older rural community: the MoVIES Project. J Am Geriatr Soc 1997; 45: 158–65

    PubMed  CAS  Google Scholar 

  21. Gurwitz JH, Soumerai SB, Avorn J. Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc 1990; 38: 542–52

    PubMed  CAS  Google Scholar 

  22. Broderick E. Prescribing patterns for nursing home residents in the US: the reality and the vision. Drugs Aging 1997; 11: 255–60

    Article  PubMed  CAS  Google Scholar 

  23. Zuniga C. Prescription médicamenteuse chez la personne âgée à l’Hôpital de Gériatrie de Genève. Data on file, 1996

    Google Scholar 

  24. Beers MH, Drag J, Hasegawa J, et al. Influence of hospitalisation on drug therapy in the elderly. J Am Geriatr Soc 1989; 37: 679–83

    PubMed  CAS  Google Scholar 

  25. Gupta S, Rappaport HM, Bennett LT. Polypharmacy among nursing home geriatric Medicaid recipients. Ann Pharmacother 1996; 30: 946–50

    PubMed  CAS  Google Scholar 

  26. Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Do too many cooks spoil the broth? Multiple physician involvement in medical management in elderly patients and potentially inappropriate drug combinations. CMAJ 1996; 154: 1177–84

    PubMed  CAS  Google Scholar 

  27. Tamblyn R. Medication use in seniors: challenges and solutions. Thérapie 1996; 51: 269–82

    PubMed  CAS  Google Scholar 

  28. Harris CM, Dajda R. The scale of repeat prescribing. Br J Gen Pract 1996; 46: 649–53

    PubMed  CAS  Google Scholar 

  29. Zermansky AG. Who controls repeats? Br J Gen Pract 1996; 46: 643–7

    PubMed  CAS  Google Scholar 

  30. Bliss MR. Prescribing for the elderly. BMJ 1981; 283: 203–6

    Article  PubMed  CAS  Google Scholar 

  31. Fourrier A, Dequae L, Chaslerie A, et al. Sociodemographic characteristics and polypharmacy in the elderly people: data from the Paquid study. Post Mark Surv 1993; 7: 291–8

    Google Scholar 

  32. Lassila HC, Stoehr GP, Ganguli M, et al. Use of prescription medication in an elderly rural population: the MoVIES Project. Ann Pharmacother 1996; 30: 589–95

    PubMed  CAS  Google Scholar 

  33. Melmon KL. Preventable drug reactions: causes and cure. N Engl J Med 1971; 284: 1361–5

    Article  PubMed  CAS  Google Scholar 

  34. Whitaker P, Wilson R, Bargh J Chapman M, et al. Use and misuse of purchased analgesics with age. Pharm J 1995; 254: 553–6

    Google Scholar 

  35. Hulka BS, Kupper LL, Cassel JC, et al. Medication use and misuse: physician-patient discrepancies. J Chronic Dis1975; 28(1): 7–21

    Article  PubMed  CAS  Google Scholar 

  36. Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Ann Intern Med 1984; 100: 258–68

    PubMed  CAS  Google Scholar 

  37. Stewart RB, Cooper JW. Polypharmacy in the aged: practical solutions. Drugs Aging 1994; 4(6): 449–61

    Article  PubMed  CAS  Google Scholar 

  38. Nolan L, O’Malley K. Prescribing for the elderly: Pt I. sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc 1988; 36: 142–9

    PubMed  CAS  Google Scholar 

  39. Carbonin P, Pahor M, Bernabei R, et al. Is age an independent risk factor for adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 1991; 39: 1093–9

    PubMed  CAS  Google Scholar 

  40. Hurwitz N, Wade OL. Intensive hospital monitoring of adverse reactions to drugs. BMJ 1969; 1: 531–6

    Article  PubMed  CAS  Google Scholar 

  41. Hoddinott BC, Gowdey CW, Coulter WK, et al. Drug reactions and errors in administration on a medical ward. CMAJ 1967; 97: 1001–6

    CAS  Google Scholar 

  42. Hanlon JT, Schmader KE, Koronkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997; 45: 945–8

    PubMed  CAS  Google Scholar 

  43. Sloan RW. Drug interactions. Am Fam Physician 1983; 27: 229–38

    PubMed  CAS  Google Scholar 

  44. Doucet J, Chassagne P, Trivalle C, et al. Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 1996; 44: 944–8

    PubMed  CAS  Google Scholar 

  45. Lindley CM, Tully MP, Paramsothy V, et al. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294–300

    Article  PubMed  CAS  Google Scholar 

  46. Borchelt M. Potentielle Neben- und Wechselwirkungen der Multimedikation im Alter: Methodik und Ergebnisse des Berliner Alterstudie. Z Gerontol Geriatr 1995; 28: 420–8

    PubMed  CAS  Google Scholar 

  47. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150: 841–5

    Article  PubMed  CAS  Google Scholar 

  48. Jankel CA, Fitterman LK. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf 1993; 9(1): 51–9

    Article  PubMed  CAS  Google Scholar 

  49. Caranasos GJ, Stewart RB, Cluff LE. Drug induced illness leading to hospitalization. JAMA 1974; 228: 713–7

    Article  PubMed  CAS  Google Scholar 

  50. Colt HG, Shapiro AP. Drug-induced illness as a cause for admission to a community hospital. J Am Geriatr Soc 1989; 37: 323–6

    PubMed  CAS  Google Scholar 

  51. Flaherty JH, Perry HM, Lynchard GS, et al. Polypharmacy and hospitalization among older home care patients. J Gerontol 2000; 55A(10): M554–9

    Google Scholar 

  52. American Society of Health-System Pharmacists. Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events and adverse drug reactions. Am J Health Syst Pharm 1998; 55: 165–6

    Google Scholar 

  53. Philips J, Beam S, Brinker A, et al. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm 2001; 58: 1835–41

    Google Scholar 

  54. Monson RA, Bond CA. The accuracy of the medical record as an index of outpatient drug therapy. JAMA 1978; 240: 2182–4

    Article  PubMed  CAS  Google Scholar 

  55. Sullivan SD, Kreling DH, Hazlet TK. Noncompliance with medication regimens and subsequent hospitalization: a literature analysis and cost of hospitalization estimate. J Res Pharm Econ 1992; 2: 19–33

    Google Scholar 

  56. Malhotra S, Karan RS, Pandhi P, et al. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001; 77: 703–7

    Article  PubMed  CAS  Google Scholar 

  57. Kidder SW. Cost-benefit of pharmacist-conducted-regimen reviews. Consult Pharm 1987; 2: 394–8

    Google Scholar 

  58. Allard J, Hebert R, Rioux M, et al. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. CMAJ 2001; 164(9): 1291–6

    PubMed  CAS  Google Scholar 

  59. Furniss L, Bums A, Craig SKL, et al. Effects of a pharmacist’s medication review in nursing homes. Br J Pschiatry 2000; 176: 563–7

    Article  CAS  Google Scholar 

  60. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996; 100(4): 428–37

    Article  PubMed  CAS  Google Scholar 

  61. Lipton HL, Bird JA. The impact of clinical pharmacists’ consultations on geriatric patients’ compliance and medical care use: a randomised controlled trial. Gerontologist 1994; 34(3): 307–15

    Article  PubMed  CAS  Google Scholar 

  62. Owens NJ, Sherburne NJ, Silliman RA, et al. The Senior Care Study. The optimal use of medications in acutely ill older patients. J Am Geriatr Soc 1990; 38: 1082–7

    PubMed  CAS  Google Scholar 

  63. Rubenstein LZ, Josephson K, Wieland D, et al. Geriatric assessment on a subacute hospital ward. Clin Geriatr Med 1987; 3: 131–43

    PubMed  CAS  Google Scholar 

  64. Williams RG, McCoy R, Frederick KR. Impact of pharmacy consultant services to homebound population. Consult Pharm 1987; 2: 479–82

    Google Scholar 

  65. Zermansky AG, Petty DR, Raynor DK, et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001; 323: 1–5

    Article  Google Scholar 

  66. Blakey SA, Hixson-Wallace JA. Clinical and economic effects of pharmacy services in a geriatric ambulatory clinic. Pharmacotherapy 2000; 20(10): 1198–203

    Article  PubMed  CAS  Google Scholar 

  67. Hood JC, Lemberger M, Stewart RB. Promoting appropriate therapy in a long-term care facility. J Am Pharm Assoc 1975; 15: 32–33, 37

    PubMed  CAS  Google Scholar 

  68. Karki SD, Mott P, Rosato L. Impact of a team approach on reducing polypharmacy. Consult Pharm 1991; 6: 133–7

    Google Scholar 

  69. Ruggiero RJ, Cohen KR, Lauletta J, et al. Further exploration of the economic impact of a pharmacist intervention at the point of polypharmacy prescribing: a follow-up study. Pharmacy and Therapeutics 1997; 22(11): 555–6, 558, 563–572, 578

    Google Scholar 

  70. Tamai IY, Rubenstein LZ, Josephson KR, et al. Impact of computerized drug profiles and a consulting pharmacist on outpatient prescribing patterns: a clinical trial. Drug Intell Clin Pharm 1987; 21(11): 890–5

    PubMed  CAS  Google Scholar 

  71. Thompson JF, McGhan WF, Ruffalo RL, et al. Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. J Am Geriatr Soc 1984; 32(2): 154–9

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this manuscript. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

  1. Clinical Gerontopharmacology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital, Geneva, Switzerland

    Victoria Rollason & Nicole Vogt

Authors
  1. Victoria Rollason
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicole Vogt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Victoria Rollason.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rollason, V., Vogt, N. Reduction of Polypharmacy in the Elderly. Drugs Aging 20, 817–832 (2003). https://doi.org/10.2165/00002512-200320110-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200320110-00003

Keywords

Search

Navigation